Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Kronmiller Matthew — Damora Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Kronmiller Matthew

Kronmiller Matthew

EVP Strategy and CBO at Damora Therapeutics, Inc. · on record since Oct 11, 2024

Insider trading activity of Kronmiller Matthew

Transactions on record: 2; since Oct 11, 2024

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jan 7, 2025

Figures computed from official regulatory filings — methodology.

Companies where Kronmiller Matthew has traded

Damora Therapeutics, Inc.2 tx · Jan 7, 2025

Track record of Kronmiller Matthew

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Kronmiller Matthew

Co-insiders of Kronmiller Matthew

Bruno JulianneDamora Therapeutics, Inc.
Burkavage BrianDamora Therapeutics, Inc.
CAIN CHRISTOPHER W.Damora Therapeutics, Inc.
Christgau StephanDamora Therapeutics, Inc.
Dallas Jayson Donald AlexanderDamora Therapeutics, Inc.
Fairmount Funds Management LLCDamora Therapeutics, Inc.
Fairmount Healthcare Co-Invest V L.P.Damora Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Fairmount Healthcare Fund II L.P.Damora Therapeutics, Inc.

Firmani LoriDamora Therapeutics, Inc.

Freve JonathanDamora Therapeutics, Inc.

GOLDFISCHER CARLDamora Therapeutics, Inc.

Harwin Peter EvanDamora Therapeutics, Inc.

Hewes L. BeckerDamora Therapeutics, Inc.

Jarrett JenniferDamora Therapeutics, Inc.

Khuong Chau QuangDamora Therapeutics, Inc.

Kiselak TomasDamora Therapeutics, Inc.

Landsittel MichaelDamora Therapeutics, Inc.

Lindmark BertilDamora Therapeutics, Inc.

Moller SorenDamora Therapeutics, Inc.

Munshi AmitDamora Therapeutics, Inc.

Novo A/SDamora Therapeutics, Inc.

Oestreich StephanieDamora Therapeutics, Inc.

OrbiMed Advisors Israel II LtdDamora Therapeutics, Inc.

ORBIMED ADVISORS LLCDamora Therapeutics, Inc.

OrbiMed Capital GP VII LLCDamora Therapeutics, Inc.

OrbiMed Genesis GP LLCDamora Therapeutics, Inc.

OrbiMed Israel GP II, L.P.Damora Therapeutics, Inc.

Pedersen AndersDamora Therapeutics, Inc.

Prener AnneDamora Therapeutics, Inc.

Sattarzadeh SherwinDamora Therapeutics, Inc.

Schambye Hans T.Damora Therapeutics, Inc.

Shapiro DavidDamora Therapeutics, Inc.

Turtle CameronDamora Therapeutics, Inc.

WECHSLER AMY BDamora Therapeutics, Inc.

Winslow GarrettDamora Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Damora Therapeutics, Inc.	Jan 7, 2025	AwardD	6,000	0.00 USD	$0	SEC
Damora Therapeutics, Inc.	Oct 11, 2024	AwardD	8,600	0.00 USD	$0	SEC